Cerebellar Rebound Nystagmus Explained as Gaze-Evoked Nystagmus Relative to an Eccentric Set Point: Implications for the Clinical Examination.


Journal

Cerebellum (London, England)
ISSN: 1473-4230
Titre abrégé: Cerebellum
Pays: United States
ID NLM: 101089443

Informations de publication

Date de publication:
Oct 2021
Historique:
pubmed: 23 2 2020
medline: 7 4 2022
entrez: 21 2 2020
Statut: ppublish

Résumé

A brain stem/cerebellar neural integrator enables stable eccentric gaze. Cerebellar loss-of-function can cause an inability to maintain gaze eccentrically (gaze-evoked nystagmus). Moreover, after returning gaze to straight ahead, the eyes may drift toward the prior eye position (rebound nystagmus). Typically, gaze-evoked nystagmus decays during continuously held eccentric gaze. We hypothesized this adaptive behavior to be prerequisite for rebound nystagmus and thus predicted a correlation between the velocity decay of gaze-evoked nystagmus and the initial velocity of rebound nystagmus. Using video-oculography, eye position was measured in 11 patients with cerebellar degeneration at nine horizontal gaze angles (15° nasal to 25° temporal) before (baseline), during, and after attempted eccentric gaze at ± 30° for 20 s. We determined the decrease of slow-phase velocity at eccentric gaze and the slow-phase velocity of the subsequent rebound nystagmus relative to the baseline. During sustained eccentric gaze, eye drift velocity of gaze-evoked nystagmus decreased by 2.40 ± 1.47°/s. Thereafter, a uniform change of initial eye drift velocity relative to the baseline (2.40 ± 1.35°/s) occurred at all gaze eccentricities. The velocity decrease during eccentric gaze and the subsequent uniform change of eye drift were highly correlated (R

Identifiants

pubmed: 32076935
doi: 10.1007/s12311-020-01118-6
pii: 10.1007/s12311-020-01118-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

751-759

Informations de copyright

© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Références

Baier B, Dieterich M. Incidence and anatomy of gaze-evoked nystagmus in patients with cerebellar lesions. Neurology. 2011;76:361–5. https://doi.org/10.1212/WNL.0b013e318208f4c3 .
doi: 10.1212/WNL.0b013e318208f4c3 pubmed: 21263137
Robinson DA. The effect of cerebellectomy on the cat’s vestibulo-ocular integrator. Brain Res. 1974;71:195–207.
doi: 10.1016/0006-8993(74)90961-5
Cannon SC, Robinson DA. Loss of the neural integrator of the oculomotor system from brain stem lesions in monkey. J Neurophysiol. 1987;57:1383–409. https://doi.org/10.1152/jn.1987.57.5.1383 .
doi: 10.1152/jn.1987.57.5.1383 pubmed: 3585473
Godaux E, Cheron G. The hypothesis of the uniqueness of the oculomotor neural integrator: direct experimental evidence in the cat. J Physiol. 1996;492(Pt 2):517–27.
doi: 10.1113/jphysiol.1996.sp021326
Leigh RJ, Zee DS. The neurology of eye movements. 5th ed. New York: Oxford University Press; 2015.
doi: 10.1093/med/9780199969289.001.0001
Zee DS, Leigh RJ, Mathieu-Millaire F. Cerebellar control of ocular gaze stability. Ann Neurol. 1980;7:37–40. https://doi.org/10.1002/ana.410070108 .
doi: 10.1002/ana.410070108 pubmed: 6244772
Bertolini G, Tarnutzer AA, Olasagasti I, Khojasteh E, Weber KP, Bockisch CJ, et al. Gaze holding in healthy subjects. PLoS One. 2013;8:e61389. https://doi.org/10.1371/journal.pone.0061389 .
doi: 10.1371/journal.pone.0061389 pubmed: 23637824 pmcid: 3637181
Westheimer G, Blair SM. Functional organization of primate oculomotor system revealed by cerebellectomy. Exp Brain Res. 1974;21:463–72.
doi: 10.1007/BF00237165
Zee DS, Yamazaki A, Butler PH, Gucer G. Effects of ablation of flocculus and paraflocculus of eye movements in primate. J Neurophysiol. 1981;46:878–99.
doi: 10.1152/jn.1981.46.4.878
Leech J, Gresty M, Hess K, Rudge P. Gaze failure, drifting eye movements, and centripetal nystagmus in cerebellar disease. Br J Ophthalmol. 1977;61:774–81.
doi: 10.1136/bjo.61.12.774
Hood JD, Kayan A, Leech J. Rebound nystagmus. Brain. 1973;96:507–26.
doi: 10.1093/brain/96.3.507
Gordon SH, Hain TC, Zee DS, Fetter M. Rebound nystagmus in normals subjects. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1986;27:158.
Beh SC, Frohman TC, Frohman EM. Neuro-ophthalmic manifestations of cerebellar disease. Neurol Clin. 2014;32:1009–80. https://doi.org/10.1016/j.ncl.2014.07.002 .
doi: 10.1016/j.ncl.2014.07.002 pubmed: 25439294
Morales-Garcia C, Cardenas JL, Arriagada C, Otte J. Clinical significance of rebound nystagmus in neuro-otological diagnosis. Ann Otol Rhinol Laryngol. 1978;87:238–42. https://doi.org/10.1177/000348947808700216 .
doi: 10.1177/000348947808700216 pubmed: 646294
Huang CC, Young YH. Vertigo with rebound nystagmus as an initial manifestation in a patient with basilar artery occlusion. Eur Arch Otorhinolaryngol. 2005;262:576–9.
doi: 10.1007/s00405-004-0874-1
Kattah JC, Talkad AV, Wang DZ, Hsieh Y-H, Newman-Toker DE. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009;40:3504–10.
doi: 10.1161/STROKEAHA.109.551234
Tarnutzer AA, Berkowitz AL, Robinson KA, Hsieh YH, Newman-Toker DE. Does my dizzy patient have a stroke? A systematic review of bedside diagnosis in acute vestibular syndrome. CMAJ. 2011;183:E571–92. https://doi.org/10.1503/cmaj.100174 .
doi: 10.1503/cmaj.100174 pubmed: 21576300 pmcid: 3114934
Abel LA, Parker L, Daroff RB, Dell'Osso LF. End-point nystagmus. Invest Ophthalmol Vis Sci. 1978;17:539–44.
pubmed: 659075
Whyte CA, Petrock AM, Rosenberg M. Occurrence of physiologic gaze-evoked nystagmus at small angles of gaze. Invest Ophthalmol Vis Sci. 2010;51:2476–8. https://doi.org/10.1167/iovs.08-3241 .
doi: 10.1167/iovs.08-3241 pubmed: 19737889
Wild F, Shallo-Hoffmann J, Muhlendyck H. Physiologic and pathologic rebound nystagmus. Description and comparison. Fortschr Ophthalmol. 1991;88:73–7.
pubmed: 2045030
Shallo-Hoffmann J, Schwarze H, Simonsz HJ, Muhlendyck H. A reexamination of end-point and rebound nystagmus in normals. Invest Ophthalmol Vis Sci. 1990;31:388–92.
pubmed: 2303336
Levo H, Aalto H, Hirvonen TPJO. Nystagmus measured with video-oculography: methodological aspects and normative data. 2004;66:101–4.
Otero-Millan J, Colpak A, Kheradmand A, Zee D, JMMiMNSotA, Translation to the Clinic GOM and Disease. Rebound nystagmus, a window into the oculomotor integrator. 2019;249:197.
Romano F, Tarnutzer AA, Straumann D, Ramat S, Bertolini G. Gaze-evoked nystagmus induced by alcohol intoxication. J Physiol. 2017;595:2161–73. https://doi.org/10.1113/JP273204 .
doi: 10.1113/JP273204 pubmed: 27981586 pmcid: 5350443
Tarnutzer AA, Bertolini G, Bockisch CJ, Straumann D, Marti S. Modulation of internal estimates of gravity during and after prolonged roll-tilts. PLoS One. 2013;8:e78079. https://doi.org/10.1371/journal.pone.0078079 .
doi: 10.1371/journal.pone.0078079 pubmed: 24205099 pmcid: 3815095
Schmahmann JD, Doyon J, McDonald D, Holmes C, Lavoie K, Hurwitz AS, et al. Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space. Neuroimage. 1999;10:233–60. https://doi.org/10.1006/nimg.1999.0459 .
doi: 10.1006/nimg.1999.0459 pubmed: 10458940
Lin CY, Young YH. Clinical significance of rebound nystagmus. Laryngoscope. 1999;109:1803–5. https://doi.org/10.1097/00005537-199911000-00015 .
doi: 10.1097/00005537-199911000-00015 pubmed: 10569411
Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, et al. Consensus paper: revisiting the symptoms and signs of cerebellar syndrome. Cerebellum. 2016;15:369–91. https://doi.org/10.1007/s12311-015-0687-3 .
doi: 10.1007/s12311-015-0687-3 pubmed: 26105056 pmcid: 5565264

Auteurs

Stefan Yu Bögli (SY)

Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.
University of Zurich, Zurich, Switzerland.
Clinical Neuroscience Center, Zurich, Switzerland.

Dominik Straumann (D)

Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.
University of Zurich, Zurich, Switzerland.
Clinical Neuroscience Center, Zurich, Switzerland.

Bernhard Schuknecht (B)

University of Zurich, Zurich, Switzerland.
Medizinisch Radiologisches Institut, Zurich, Switzerland.

Giovanni Bertolini (G)

Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.
University of Zurich, Zurich, Switzerland.
Clinical Neuroscience Center, Zurich, Switzerland.

Alexander A Tarnutzer (AA)

Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland. alexander.tarnutzer@access.uzh.ch.
University of Zurich, Zurich, Switzerland. alexander.tarnutzer@access.uzh.ch.
Clinical Neuroscience Center, Zurich, Switzerland. alexander.tarnutzer@access.uzh.ch.
Neurology, Cantonal Hospital of Baden, Baden, Switzerland. alexander.tarnutzer@access.uzh.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH